Anahita Najafi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anahita Najafi has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Abdorreza Naser Moghadasi
Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationAbolfazl Bariklou
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationAli Bitaraf
School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
1 shared publicationAlireza Hasanzadeh
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationAmir Naziriyan
School of Medicine, Tehran University of Medical Sciences , Tehran
1 shared publication- Anahita Najafi
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 6 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (7) , e72599
Evaluating the Effect of the EAT‐Lancet Diet on Pemphigus Vulgaris Severity: Insights From a Cross‐Sectional Study
Background and Aims: This study investigated the association between adherence to the EAT‐Lancet diet—a predominantly plant‐based, anti‐inflammatory dietary pattern—and the severity of pemphigus vulgaris (PV), a rare autoimmune blistering disease. Methods: This cross‐sectional study was conducted in an Iranian population with a high incidence of PV and included 138 newly diagnosed patients. Disease severity was assessed using the Pemphigus Disease Area Index (PDAI). Results: The findings revealed a significant inverse association between adherence to the EAT‐Lancet diet and PV severity. After adjus[tment for potential confounders, including age, sex, BMI, corticosteroid use, and caloric and carbohydrate intake, higher adherence to the diet remained consistently associated with markedly lower odds of severe PV (OR: 0.10; 95% CI: 0.02–0.40; p for trend = 0.001), suggesting that dietary patterns may influence disease activity and progression. Conclusion: Although this cross‐sectional study has several important limitations—including the inability to establish temporality, potential reverse causation, and a small number of severe cases—the observed association between higher adherence to the EAT‐Lancet diet and lower pemphigus vulgaris severity should be interpreted as hypothesis‐generating. These findings may justify further research in larger longitudinal cohorts or dietary intervention trials, but they do not provide sufficient evidence to support dietary modification as an adjunctive clinical strategy for PV management at this stage.
- 6 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (7) , e72599
Open AccessEvaluating the Effect of the EAT‐Lancet Diet on Pemphigus Vulgaris Severity: Insights From a Cross‐Sectional Study
Background and Aims: This study investigated the association between adherence to the EAT‐Lancet diet—a predominantly plant‐based, anti‐inflammatory dietary pattern—and the severity of pemphigus vulgaris (PV), a rare autoimmune blistering disease. Methods: This cross‐sectional study was conducted in an Iranian population with a high incidence of PV and included 138 newly diagnosed patients. Disease severity was assessed using the Pemphigus Disease Area Index (PDAI). Results: The findings revealed a significant inverse association between adherence to the EAT‐Lancet diet and PV severity. After adjus[tment for potential confounders, including age, sex, BMI, corticosteroid use, and caloric and carbohydrate intake, higher adherence to the diet remained consistently associated with markedly lower odds of severe PV (OR: 0.10; 95% CI: 0.02–0.40; p for trend = 0.001), suggesting that dietary patterns may influence disease activity and progression. Conclusion: Although this cross‐sectional study has several important limitations—including the inability to establish temporality, potential reverse causation, and a small number of severe cases—the observed association between higher adherence to the EAT‐Lancet diet and lower pemphigus vulgaris severity should be interpreted as hypothesis‐generating. These findings may justify further research in larger longitudinal cohorts or dietary intervention trials, but they do not provide sufficient evidence to support dietary modification as an adjunctive clinical strategy for PV management at this stage.
- Open Access
- 3 April 2026
- Published by Elsevier in Physica Medica
- Vol. 145, 105797
Deep learning for dentomaxillofacial cone-beam computed tomography enhancement: A systematic review and meta-analysis
- 3 April 2026
- Published by Elsevier in Physica Medica
- Vol. 145, 105797
Open AccessDeep learning for dentomaxillofacial cone-beam computed tomography enhancement: A systematic review and meta-analysis
- Open Access
- 26 February 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Circulating IncRNAs and Their Association With Ischemic Stroke Severity and Prognosis: A Systematic Review and Meta‐Analysis
Background and Aims: Stroke is the most significant contributor to morbidity worldwide. Prognostication in stroke patients could lead to better planning and care and, subsequently, better outcomes. Recently, lncRNAs have become a hot topic as biomarkers of different diseases. This study aims to systematically assess the utility of lncRNAs in stroke prognosis. Methods: We systematically searched for relevant articles in Medline (via PubMed interface), EMBASE, Web of Science, and Scopus databases from their inception to April 6th, 2024. Inclusions were limited to original peer‐reviewed papers in English that assessed the correlation between circulating lncRNA levels and stroke severity (all subtypes) and/or prognosis. Completeness of the report was evaluated with the “Strengthening the Reporting of Observational Studies in Epidemiology” (STROBE) checklist, and quality assessment was performed with “Quality in Prognosis Studies” (QUIPS) and “Newcastle Ottawa scale” (NOS) checklists. Results: Of the 1134 unique citations gathered, 60 were assessed in full text for inclusion, and 30 were included in the final analysis. Although our search strategy covered all stroke subtypes, no eligible studies were found for hemorrhagic stroke; thus, only ischemic stroke and TIA populations were included. We included 30 studies in our analysis, which included 3719 patients and 4433 data points. The pooled correlation between circulating lncRNAs and NIHSS was 0.52 (CI95%:0.43–0.60), and circulating lncRNAs and the modified Rankin Scale was 0.49 (CI95%:0.26–0.67). The pooled odds ratio for the mortality prediction was 1.55 (CI 95%:1.26–1.92). Quality assessment of included studies showed that most of the studies had a low risk of bias and high completeness of report. Conclusion: LncRNAs show modest to moderate predictive accuracy in assessing stroke severity and prognosis. While these findings are encouraging, Further research is needed to solidify their utility in stroke care.
- 26 February 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Open AccessCirculating IncRNAs and Their Association With Ischemic Stroke Severity and Prognosis: A Systematic Review and Meta‐Analysis
Background and Aims: Stroke is the most significant contributor to morbidity worldwide. Prognostication in stroke patients could lead to better planning and care and, subsequently, better outcomes. Recently, lncRNAs have become a hot topic as biomarkers of different diseases. This study aims to systematically assess the utility of lncRNAs in stroke prognosis. Methods: We systematically searched for relevant articles in Medline (via PubMed interface), EMBASE, Web of Science, and Scopus databases from their inception to April 6th, 2024. Inclusions were limited to original peer‐reviewed papers in English that assessed the correlation between circulating lncRNA levels and stroke severity (all subtypes) and/or prognosis. Completeness of the report was evaluated with the “Strengthening the Reporting of Observational Studies in Epidemiology” (STROBE) checklist, and quality assessment was performed with “Quality in Prognosis Studies” (QUIPS) and “Newcastle Ottawa scale” (NOS) checklists. Results: Of the 1134 unique citations gathered, 60 were assessed in full text for inclusion, and 30 were included in the final analysis. Although our search strategy covered all stroke subtypes, no eligible studies were found for hemorrhagic stroke; thus, only ischemic stroke and TIA populations were included. We included 30 studies in our analysis, which included 3719 patients and 4433 data points. The pooled correlation between circulating lncRNAs and NIHSS was 0.52 (CI95%:0.43–0.60), and circulating lncRNAs and the modified Rankin Scale was 0.49 (CI95%:0.26–0.67). The pooled odds ratio for the mortality prediction was 1.55 (CI 95%:1.26–1.92). Quality assessment of included studies showed that most of the studies had a low risk of bias and high completeness of report. Conclusion: LncRNAs show modest to moderate predictive accuracy in assessing stroke severity and prognosis. While these findings are encouraging, Further research is needed to solidify their utility in stroke care.
- Open Access
- 11 June 2025
- Published by Brieflands in Iranian Journal of Psychiatry and Behavioral Sciences
- Vol. 19 (3)
Cannabis and Methamphetamine Use Patterns in a Psychiatric Inpatient Setting in Iran
Background: Substance use is associated with psychiatric disorders, contributing to negative outcomes and exacerbating existing conditions. Objectives: This study aimed to investigate the prevalence and patterns of illicit drug use, focusing on cannabis and methamphetamine, in a psychiatric inpatient setting in Iran. Methods: Three hundred adult psychiatric inpatients were included in the study, and data on demographics, substance use patterns, and clinical characteristics were collected. The World Health Organization’s alcohol, smoking, and substance involvement screening test (WHO-ASSIST) was used to screen for substance-related patterns and risks among patients who used methamphetamine or cannabis in the past three months. Results: Among the participants (median age: 35.0 years, 65.3% male), recent substance use was reported by 38.0%, with methamphetamine and cannabis reported by 15.0% and 11.7%, respectively. These were less prevalent compared to alcohol and opioid substances, which were reported by 19.3% and 19%, respectively. Recent cannabis or methamphetamine use was associated with aggression and polysubstance use disorders. Conclusions: The findings revealed that recent cannabis and methamphetamine use were associated with aggression and polysubstance use disorders among psychiatric inpatients. Opioids were the most prevalent illicit drugs consumed.
- 11 June 2025
- Published by Brieflands in Iranian Journal of Psychiatry and Behavioral Sciences
- Vol. 19 (3)
Open AccessCannabis and Methamphetamine Use Patterns in a Psychiatric Inpatient Setting in Iran
Background: Substance use is associated with psychiatric disorders, contributing to negative outcomes and exacerbating existing conditions. Objectives: This study aimed to investigate the prevalence and patterns of illicit drug use, focusing on cannabis and methamphetamine, in a psychiatric inpatient setting in Iran. Methods: Three hundred adult psychiatric inpatients were included in the study, and data on demographics, substance use patterns, and clinical characteristics were collected. The World Health Organization’s alcohol, smoking, and substance involvement screening test (WHO-ASSIST) was used to screen for substance-related patterns and risks among patients who used methamphetamine or cannabis in the past three months. Results: Among the participants (median age: 35.0 years, 65.3% male), recent substance use was reported by 38.0%, with methamphetamine and cannabis reported by 15.0% and 11.7%, respectively. These were less prevalent compared to alcohol and opioid substances, which were reported by 19.3% and 19%, respectively. Recent cannabis or methamphetamine use was associated with aggression and polysubstance use disorders. Conclusions: The findings revealed that recent cannabis and methamphetamine use were associated with aggression and polysubstance use disorders among psychiatric inpatients. Opioids were the most prevalent illicit drugs consumed.
- 10 August 2023
- Published by Elsevier in The American Journal of Surgery
- Vol. 228, 102-106
Laparoscopic gastric plication: A long-term follow-up and comparison of outcomes in severe vs. non-severe obesity
- 10 August 2023
- Published by Elsevier in The American Journal of Surgery
- Vol. 228, 102-106
Laparoscopic gastric plication: A long-term follow-up and comparison of outcomes in severe vs. non-severe obesity
- Open Access
- 1 July 2023
- Published by SAGE Publications in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Vol. 9 (3)
The association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort
Background: Although upper respiratory infections (URIs) are linked to multiple sclerosis (MS) attacks, SARS-COV2 has not been compared to URIs for attack rates. Objectives: This study aimed to evaluate the attack rate and the results of neuroimaging in MS patients with URIs caused by COVID-19 and non-COVID-19 infections (NC-URI). Methods: From May 2020 to April 2021, we followed 362 patients with relapsing-remitting MS in a prospective cohort design. Patients were monitored regularly every 12 weeks; an magnetic resonance imaging (MRI) scan was performed at enrollment and every time a relapse occurred. Poisson analysis was used to determine exacerbation rate ratios (RR) and the MRI parameters were tested using chi-square analysis. Results: 347 patients with an average age of 38 and a female ratio of 86% were included. A RR of 2.24 ( p < 0.001) was observed for exacerbations during the at-risk period (ARP). Attacks related to COVID-19 (RR = 2.13, p = 0.001) and NC-URIs (RR = 2.39, p < 0.001) were comparable regarding the increased risk of exacerbation ( p = 0.62). Exacerbations within or outside the ARP did not significantly alter the number of baseline GAD-enhancing lesions ( p > 0.05 for both). Conclusion: COVID-19 has been shown to increase the risk of MS exacerbations, like other viral URIs.
- 1 July 2023
- Published by SAGE Publications in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Vol. 9 (3)
Open AccessThe association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort
Background: Although upper respiratory infections (URIs) are linked to multiple sclerosis (MS) attacks, SARS-COV2 has not been compared to URIs for attack rates. Objectives: This study aimed to evaluate the attack rate and the results of neuroimaging in MS patients with URIs caused by COVID-19 and non-COVID-19 infections (NC-URI). Methods: From May 2020 to April 2021, we followed 362 patients with relapsing-remitting MS in a prospective cohort design. Patients were monitored regularly every 12 weeks; an magnetic resonance imaging (MRI) scan was performed at enrollment and every time a relapse occurred. Poisson analysis was used to determine exacerbation rate ratios (RR) and the MRI parameters were tested using chi-square analysis. Results: 347 patients with an average age of 38 and a female ratio of 86% were included. A RR of 2.24 ( p < 0.001) was observed for exacerbations during the at-risk period (ARP). Attacks related to COVID-19 (RR = 2.13, p = 0.001) and NC-URIs (RR = 2.39, p < 0.001) were comparable regarding the increased risk of exacerbation ( p = 0.62). Exacerbations within or outside the ARP did not significantly alter the number of baseline GAD-enhancing lesions ( p > 0.05 for both). Conclusion: COVID-19 has been shown to increase the risk of MS exacerbations, like other viral URIs.
- Open Access
- 21 June 2022
- Published by Oxford University Press (OUP) in Skin Health and Disease
- Vol. 2 (3) , e142
Indirect Immunofluorescence on Rat Bladder Epithelium in Patients with Pemphigus Vulgaris with an Extended Follow-Up
Background: Indirect immunofluorescence (IIF) on rat bladder epithelium (RBE) has been widely used to detect anti-plakin antibodies present in paraneoplastic pemphigus (PNP). However, anti-plakin antibodies have also been found in a group of patients with pemphigus vulgaris (PV). Objectives: To assess the reactivity rate of PV sera in IIF using RBE as substrate and the diagnostic usefulness of the aforementioned test. Methods: Patients diagnosed with PV presenting to Razi Hospital, Tehran, Iran, were recruited. The patients' demographics, disease severity, and response to the initial treatment were recorded. Sera were collected and tested by IIF on RBE and by desmoglein 3/1 (Dsg 3/1) enzyme-linked immunosorbent assay. Patients were followed up closely for a mean of 53.9 months for any evidence of malignancy. Results: Forty-six patients were enroled (mean age of 42.9 years old, 31 females). Nine sera (19.6%) showed reactivity in IIF on RBE. Mean serum anti-Dsg levels did not differ significantly among the two groups with positive and negative IIF results. Negative anti-Dsg3 was related to a higher positive rate in IIF on RBE. There was no significant correlation between the reactivity of IIF on RBE and patients' demographic, clinical, or serological characteristics. Conclusions: IIF on RBE is a sensitive test for detecting antibodies against plakins. However, it has a relatively high false-positive rate in PV, probably due to the epitope spreading phenomenon. This test should be suggested when there is a clinical or immunohistopathological suspicion of PNP and should be interpreted with caution.
- 21 June 2022
- Published by Oxford University Press (OUP) in Skin Health and Disease
- Vol. 2 (3) , e142
Open AccessIndirect Immunofluorescence on Rat Bladder Epithelium in Patients with Pemphigus Vulgaris with an Extended Follow-Up
Background: Indirect immunofluorescence (IIF) on rat bladder epithelium (RBE) has been widely used to detect anti-plakin antibodies present in paraneoplastic pemphigus (PNP). However, anti-plakin antibodies have also been found in a group of patients with pemphigus vulgaris (PV). Objectives: To assess the reactivity rate of PV sera in IIF using RBE as substrate and the diagnostic usefulness of the aforementioned test. Methods: Patients diagnosed with PV presenting to Razi Hospital, Tehran, Iran, were recruited. The patients' demographics, disease severity, and response to the initial treatment were recorded. Sera were collected and tested by IIF on RBE and by desmoglein 3/1 (Dsg 3/1) enzyme-linked immunosorbent assay. Patients were followed up closely for a mean of 53.9 months for any evidence of malignancy. Results: Forty-six patients were enroled (mean age of 42.9 years old, 31 females). Nine sera (19.6%) showed reactivity in IIF on RBE. Mean serum anti-Dsg levels did not differ significantly among the two groups with positive and negative IIF results. Negative anti-Dsg3 was related to a higher positive rate in IIF on RBE. There was no significant correlation between the reactivity of IIF on RBE and patients' demographic, clinical, or serological characteristics. Conclusions: IIF on RBE is a sensitive test for detecting antibodies against plakins. However, it has a relatively high false-positive rate in PV, probably due to the epitope spreading phenomenon. This test should be suggested when there is a clinical or immunohistopathological suspicion of PNP and should be interpreted with caution.